DOCA-PHARMA
ActiveSummary
DOCA-PHARMA has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€79,753) and a net result of -€64,546. Its solvency ranks better than 5% of 1,592 sector peers (NACE 75, financial year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
Group and network
Connections & network
2 office holdersThe network starts from this company’s directors. Other companies they run appear here as nodes.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.